Avaleht/Aktsiad/NBTX

NBTX

USD

Nanobiotix S.A. American Depositary Shares

$19.330+0.560 (2.983%)

Reaalajas hind

Healthcare

Biotehnoloogia

Prantsusmaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$18.770

Kõrge

$20.261

Madal

$18.580

Maht

0.07M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.1B

Tööstusharu

Biotehnoloogia

Riik

France

Kauplemisstatistika

Keskmine maht

0.08M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $2.76Praegune $19.330Kõrge $30.35

Seotud uudised

3. nov 2025 · 21:15

GlobeNewswire

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

PARIS and CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ:NBTX - the "Company"), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand

Vaata rohkem

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

31. okt 2025 · 07:00

GlobeNewswire

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

$71 million in funding would extend Nanobiotix cash visibility into early 2028Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancerFinancing establishes financial

Vaata rohkem

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

24. okt 2025 · 06:00

GlobeNewswire

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

PARIS and CAMBRIDGE, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ:NBTX – the ‘‘Company''), a late-stage clinical biotechnology company pioneering physics-based approaches to expand

Vaata rohkem